Table 2.
PIT, aaIPI, and response before HDT/ASCT in AITL Patients
| N | % | N | % | ||||
|---|---|---|---|---|---|---|---|
| PIT | Response before HDT/ASCT | ||||||
| 0 | 4 | 28.6% | CR1 | 8 | 57.1% | ||
| 1 | 6 | 42.9% | PR1 | 2 | 14.3% | ||
| 2 | 1 | 7.1% | CR2 | 2 | 14.3% | ||
| Unknown | 3 | 21.4% | PR2 | 1 | 7.1% | ||
| aaIPI | SD/PD | 1 | 7.1% | ||||
| 0 | 0 | 0.0% | |||||
| 1 | 4 | 28.6% | |||||
| 2 | 7 | 50.0% | |||||
| Unknown | 3 | 21.4% | |||||
PIT: Prognostic Index for T-cell lymphoma; aaIPI: age adjusted International Prognostic Index; CR1: complete remission after first-line treatment; PR1: partial remission after first-line treatment; CR2: complete remission after second-line treatment; PR2: partial remission after second-line treatment; SD: Stable disease; PD: Progressive disease.